<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="3-part\PMC7058406\results\search\country\results.xml">
  <result pre="ongoing outbreak of highly pathogenic Zaire Ebola virus (EBOV) in" exact="Democratic Republic of the Congo" post="(DRC) has resulted in more than 3,393 human cases"/>
  <result pre="pathogenic Zaire Ebola virus (EBOV) in Democratic Republic of the" exact="Congo" post="(DRC) has resulted in more than 3,393 human cases"/>
  <result pre="trials, with the rVSV-EBOV vaccine now being licensed in the" exact="United States" post="and Europe (Ewer et al., 2016, Henao-Restrepo et al.,"/>
  <result pre="this vaccine was demonstrated in a ring vaccination study in" exact="Guinea" post="during an outbreak in 2015 (Henao-Restrepo et al., 2015,"/>
  <result pre="modified vaccinia Ankara (MVA)-vectored vaccine that also contains genes encoding" exact="Sudan" post="ebolavirus and Marburgvirus glycoprotein and Tai Forest nucleoprotein. Quantitative"/>
  <result pre="a pooled convalescent plasma (sample #92) was obtained from six" exact="Sierra Leone" post="patients who recovered from EVD and did not receive"/>
  <result pre="isotype. Plasma sample #92 obtained from six EVD survivors in" exact="Sierra Leone" post="(who did not receive any experimental treatment) contained 8.3%"/>
  <result pre="plasma specimens from survivors (#28, #43, and #79), pooled EVD" exact="Sierra Leone" post="survivor plasma (#92), and pooled plasma from vaccinated individuals"/>
  <result pre="antibodies in sample #92 obtained from six EVD survivors in" exact="Sierra Leone" post="(who did not receive any experimental treatment) is speculated"/>
  <result pre="(Wilkinson et al., 2017). Plasma pool #92 obtained from six" exact="Sierra Leone" post="survivors who did not receive any experimental treatment showed"/>
  <result pre="in #28, #43, and #79 that were recognized by the" exact="Sierra Leone" post="patients (#92) who did not receive any Ebola-specific antibody"/>
  <result pre="transmission of ebola virus from healthcare worker to 238 contacts," exact="United Kingdom," post="December 2014Emerg. Infect. Dis.2320172081208429148368 DyeJ.M.HerbertA.S.KuehneA.I.BarthJ.F.MuhammadM.A.ZakS.E.OrtizR.A.PrugarL.I.PrattW.D.Postexposure antibody prophylaxis protects nonhuman"/>
  <result pre="rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the" exact="Guinea" post="ring vaccination cluster-randomised trialLancet386201585786626248676 HoltsbergF.W.ShuleninS.VuH.HowellK.A.PatelS.J.GunnB.KarimM.LaiJ.R.FreiJ.C.NyakaturaE.K.Pan-ebolavirus and pan-filovirus mouse monoclonal"/>
  <result pre="HoltsbergF.W.ShuleninS.VuH.HowellK.A.PatelS.J.GunnB.KarimM.LaiJ.R.FreiJ.C.NyakaturaE.K.Pan-ebolavirus and pan-filovirus mouse monoclonal antibodies: protection against Ebola and" exact="Sudan" post="virusesJ. Virol.90201526627826468533 JonesS.M.FeldmannH.StroherU.GeisbertJ.B.FernandoL.GrollaA.KlenkH.D.SullivanN.J.VolchkovV.E.FritzE.A.Live attenuated recombinant vaccine protects nonhuman primates"/>
 </snippets>
</snippetsTree>
